Live Breaking News & Updates on Single Arm Continued Access

Boston Scientific Corporation (NYSE:BSX) Q4 2023 Earnings Call Transcript January 31, 2024 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0.55, expectations were $0.51. BSX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to the […] ....

Daniel Brennan , Lauren Tengler , Jon Monson , Hedge Fund , Access Solutions , Structural Heart Valves , Single Arm Continued Access , Rhythm Management , Global Controller , Chief Accounting Officer , Investor Relations , Sally Devoe , Hedge Fund Manager Charles Paquelet , Boston Scientific Corporation , Fourth Quarter , Dan Brennan , Basis Points , Lauren Tengler , Organic Growth , Operational Revenue , Operating Margin , Mike Mahoney , Operational Revenue Growth ,